Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |